According to Aurobindo Pharma 's latest financial reports the company's current revenue (TTM ) is $3.57 Billion USD. In 2023 the company made a revenue of $3.33 Billion USD an increase over the revenue in the year 2022 that were of $3.01 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.